HDAC9 and early-onset autosomal dominant Alzheimer disease: There is accumulating evidence that HDAC inhibitors exhibit neuroprotective and neuroregenerative properties in animal models of various neurological diseases including Alzheimer's disease and ischaemic stroke 6, 7.